Cambridge, MA · Founded 2015 · Privately Held (backing)
Developer of human-compatible engineered organs and cells designed to address the global shortage of transplantable organs. Egenesis is based in Cambridge, MA and was founded in 2015. Its last known valuation is $330 million. It has raised $454 million across 5 recorded rounds; the latest was a $25.4 million debt round in Feb 2024.
Last price · $/share
—
Implied valuation
$330.0M
Total raised
$454.0M
Last round
Debt
Feb 2024
Team — not yet on record
No current team members for Egenesis are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Egenesis with a free account
·The complete investor list: 37 names
·Watch Egenesis: the Monday email on marks, rounds and moves
